Bioprosthetic heart valves (BHVs) largely circumvent the need for long‐term anticoagulation
compared with mechanical valves but are increasingly susceptible to deterioration and …

Aortic valve-in-valve (ViV) procedures are increasingly performed for the treatment of
surgical bioprosthetic valve failure in patients at intermediate to high surgical risk. Although …

Objectives Reoperation for structural valve deterioration (SVD) of bioprosthetic mitral valves
carries a presumed high operative risk, and transcatheter mitral valve-in-valve implantation …

Background Favourable early outcomes have been reported following valve-in-valve
transcatheter mitral valve replacement (TMVR). However, reports of long-term outcomes are …

OBJECTIVES Comparisons of long-term clinical outcomes of mitral valve replacement
(MVR) between bovine pericardial and porcine bioprostheses are conflicting, with limited …

Objectives Transcatheter aortic valve implantation (TAVI) remains the preferred strategy for
high-risk or elderly individuals with aortic valve (AV) stenosis who are not considered to be …

In the last years, there has been a trend to prefer biological prostheses, especially among
young patients, with the aim to avoid anticoagulant treatment. Surgical tissue valves have so …

Objectives Long-term echocardiographic reports on mitral valve (MV) porcine xenograft
bioprosthesis (Epic) are lacking, and postreintervention outcomes of failed Epic are …

OBJECTIVES This study was conducted to examine the incidence and modes of the
bioprosthetic valve failure of the porcine valve in the mitral position and compare them with …

Background This study aimed to compare long-term outcomes, including durability, after
bovine pericardial valve replacement with those after porcine mitral valve replacement …